Opella Healthcare Belgium NV/SA (Public limited company)
Opella Healthcare Belgium NV/SA is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0753.785.218. It was founded on 08-09-2020. Its registered office is in Machelen (Brab.). Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 20 672 701 and a profit of € 1 113 246. These accounts report 39.1 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 2 of its last 4 financial years.
Information last updated on 17-10-2026.
Company information
Key figures of Opella Healthcare Belgium NV/SA
| 2025 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € 1 113 246 | € 2 358 285+510 % | € 386 486 | € -11 783 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € 20 672 701 | € 21 481 313+12 % | € 19 123 028+2 % | € 18 736 542 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 32 304 565 | € 33 286 221+8 % | € 30 935 270+22 % | € 25 440 773 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | - | - | - | - |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 39.1 | 45.5+4 % | 43.8+1 % | 43.5 |
Financial estimate
- 1 Shareholders
Similar companies
Other companies in the same activity in Machelen (Brab.).
| Company | Town |
|---|---|
| ROSTVERTOL INTERNATIONAL | 1831 Machelen (Brab.) |
| Medline International Belgium | 1831 Machelen (Brab.) |
| CM Land | 1831 Machelen (Brab.) |
Frequently asked questions
Is Opella Healthcare Belgium NV/SA still active? Yes. The Crossroads Bank for Enterprises lists Opella Healthcare Belgium NV/SA as active.
What is the VAT number of Opella Healthcare Belgium NV/SA? The VAT number of Opella Healthcare Belgium NV/SA is BE 0753.785.218.
When was Opella Healthcare Belgium NV/SA founded? Opella Healthcare Belgium NV/SA was founded on 08-09-2020.
What is the address of Opella Healthcare Belgium NV/SA? The current registered office of Opella Healthcare Belgium NV/SA is Leonardo da Vincilaan 19, 1831 Machelen (Brab.).
When did Opella Healthcare Belgium NV/SA last file annual accounts? The latest annual accounts of Opella Healthcare Belgium NV/SA were filed on 02-07-2026.
Does Opella Healthcare Belgium NV/SA file its annual accounts on time? Opella Healthcare Belgium NV/SA filed its annual accounts within the legal deadline for 2 of its last 4 financial years. Late: 2022, 2024.
How many employees does Opella Healthcare Belgium NV/SA have? Opella Healthcare Belgium NV/SA employs 39.1 full-time equivalents according to its most recent annual accounts.
Is Opella Healthcare Belgium NV/SA financially healthy? Addrly gives Opella Healthcare Belgium NV/SA a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is Opella Healthcare Belgium NV/SA profitable? The annual accounts of Opella Healthcare Belgium NV/SA for 2025 show a profit of € 1 113 246.
What is the equity of Opella Healthcare Belgium NV/SA? The equity of Opella Healthcare Belgium NV/SA was € 20 672 701 at the close of the 2025 financial year.
Who are the directors of Opella Healthcare Belgium NV/SA? The annual accounts of Opella Healthcare Belgium NV/SA record 5 mandates. The names, roles and dates are visible with a free account.
Can Opella Healthcare Belgium NV/SA receive Peppol e-invoices? Yes. Opella Healthcare Belgium NV/SA is registered on the Peppol network and can receive structured electronic invoices.
What does Opella Healthcare Belgium NV/SA do? The main activity of Opella Healthcare Belgium NV/SA is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.